Evidence map›Paper›PMID 33419917›Full record

ArticleBMJ open2021

Study design, rationale and methods of the Revitalising Informal Settlements and their Environments (RISE) study: a cluster randomised controlled trial to evaluate environmental and human health impacts of a water-sensitive intervention in informal settlements in Indonesia and Fiji.

Karin Leder, John J Openshaw, Pascale Allotey, Ansariadi Ansariadi, S Fiona Barker, Kerrie Burge, Thomas F Clasen, Steven L Chown, Grant A Duffy, Peter A Faber and 24 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Causal drivers of mosquito abundance in urban informal settlements.Environmental research letters : ERL [Web site] · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 11 institutions in 6 countries.

Karin LederSchool of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia karin.leder@monash.edu.ORCID 0000-0003-1368-1039
John J OpenshawInfectious Diseases and Geographic Medicine Division, Stanford University, Stanford, California, USA.
Pascale AlloteyInternational Institute for Global Health, United Nations University, Kuala Lumpur, Malaysia.
Ansariadi AnsariadiPublic Health Faculty, Hasanuddin University, Makassar, Sulawesi Selatan, Indonesia.ORCID 0000-0002-9692-6136
S Fiona BarkerSchool of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0002-9203-5766
Kerrie BurgeCRC for Water Sensitive Cities, Monash University, Melbourne, Victoria, Australia.
Thomas F ClasenGangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.ORCID 0000-0003-4062-5788
Steven L ChownSchool of Biological Sciences, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0001-6069-5105
Grant A DuffySchool of Biological Sciences, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0002-9031-8164
Peter A FaberSchool of Biological Sciences, Monash University, Melbourne, Victoria, Australia.
Genie FlemingSchool of Biological Sciences, Monash University, Melbourne, Victoria, Australia.
Andrew B ForbesSchool of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0003-4269-914X
Matthew FrenchMonash Sustainable Development Institute, Monash University, Melbourne, Victoria, Australia.
Chris GreeningDepartment of Microbiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0001-7616-0594
Rebekah HenryCivil Engineering, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0001-6530-8557
Ellen HigginsonCambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, Cambridgeshire, UK.
David W JohnstonCentre for Health Economics, Monash Business School, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0003-3185-2890
Rachael LappanDepartment of Microbiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
Audrie LinDivision of Epidemiology and Biostatistics, School of Public Health, University of California Berkeley, Berkeley, California, USA.
Stephen P LubyInfectious Diseases and Geographic Medicine Division, Stanford University, Stanford, California, USA.ORCID 0000-0001-5385-899X
David McCarthyCivil Engineering, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0001-8845-6501
Joanne E O'TooleSchool of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0002-3161-9215
Diego Ramirez-LoveringArt, Design and Architecture, Monash University, Caulfield, Victoria, Australia.ORCID 0000-0003-0774-4929
Daniel D ReidpathMonash University - Malaysia Campus, Bandar Sunway, Selangor, Malaysia.ORCID 0000-0002-8796-0420
Julie A SimpsonCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-2660-2013
Sheela S SinharoyHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.ORCID 0000-0003-3077-3824
Rohan SweeneyCentre for Health Economics, Monash Business School, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0002-3243-9523
Ruzka R TarucPublic Health Faculty, Hasanuddin University, Makassar, Sulawesi Selatan, Indonesia.
Autiko TelaSchool of Public Health and Primary Care, Fiji National University, College of Medicine, Nursing and Health Sciences, Tamavua Campus, Suva, Rewa, Fiji.
Amelia R TuragabeciSchool of Public Health and Primary Care, Fiji National University, College of Medicine, Nursing and Health Sciences, Tamavua Campus, Suva, Rewa, Fiji.ORCID 0000-0002-4923-7397
Jane WardaniMonash Sustainable Development Institute, Monash University, Melbourne, Victoria, Australia.
Tony WongCRC for Water Sensitive Cities, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0001-8649-2816
Rebekah BrownMonash Sustainable Development Institute, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0002-8689-7562
RISE Consortium
Monash University · AUCooperative Research Centre for Water Sensitive Cities · AUEmory University · USFiji National University · FJHasanuddin University · IDStanford University · USMonash University Malaysia · MYThe University of Melbourne · AUUnited Nations University-International Institute for Global Health · MYUniversity of California, Berkeley · USUniversity of Cambridge · GB

Funding

Wellcome TrustWellcome Trust 205222/Z/16/Z
6 · The paper itself

Abstract

introductionIncreasing urban populations have led to the growth of informal settlements, with contaminated environments linked to poor human health through a range of interlinked pathways. Here, we describe the design and methods for the Revitalising Informal Settlements and their Environments (RISE) study, a transdisciplinary randomised trial evaluating impacts of an intervention to upgrade urban informal settlements in two Asia-Pacific countries. METHODS AND ANALYSIS: RISE is a cluster randomised controlled trial among 12 settlements in Makassar, Indonesia, and 12 in Suva, Fiji. Six settlements in each country have been randomised to receive the intervention at the outset; the remainder will serve as controls and be offered intervention delivery after trial completion. The intervention involves a water-sensitive approach, delivering site-specific, modular, decentralised infrastructure primarily aimed at improving health by decreasing exposure to environmental faecal contamination. Consenting households within each informal settlement site have been enrolled, with longitudinal assessment to involve health and well-being surveys, and human and environmental sampling. Primary outcomes will be evaluated in children under 5 years of age and include prevalence and diversity of gastrointestinal pathogens, abundance and diversity of antimicrobial resistance (AMR) genes in gastrointestinal microorganisms and markers of gastrointestinal inflammation. Diverse secondary outcomes include changes in microbial contamination; abundance and diversity of pathogens and AMR genes in environmental samples; impacts on ecological biodiversity and microclimates; mosquito vector abundance; anthropometric assessments, nutrition markers and systemic inflammation in children; caregiver-reported and self-reported health symptoms and healthcare utilisation; and measures of individual and community psychological, emotional and economic well-being. The study aims to provide proof-of-concept evidence to inform policies on upgrading of informal settlements to improve environments and human health and well-being. ETHICS: Study protocols have been approved by ethics boards at Monash University, Fiji National University and Hasanuddin University. TRIAL REGISTRATION NUMBER: ACTRN12618000633280; Pre-results.

Indexed as

WaterAsiaChildChild, PreschoolFijiHumansIndonesiaRandomized Controlled Trials as TopicUrban PopulationWaterepidemiologygastrointestinal infectionspublic healthtropical medicine

Identifiers

PMID33419917
PMCPMC7798802
OpenAlexW3120557810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.